PLENARY SESSION
Saturday, June 15, 2013 - 8:30 am – 10:20 am
CONTROVERSIES
Co-Chairs: Drs. Mervyn Deitel, Teodor Grantcharov
Canadian Room
8:30 am - 9:10 am - DEBATE
Mechanisms of Improvement of Glycemic Control After Bariatric Surgery: Restriction versus Gut Hormones Restriction
 |
André Carpentier, MD, FRCPC, CSPQCIHR-GSK Chair in Diabetes, Centre de recherche clinique Étienne-Le Bel Centre hospitalier universitaire de Sherbrooke, Université de Sherbrooke Dr. Carpentier is the recipient of the CIHR-GSK Chair in Diabetes and professor and clinician-scientist in the Departments of Medicine, Faculty of Medicine at the Université de Sherbrooke and the Centre de recherche clinique Étienne-Le Bel. He is also the director of the university’s Diabetes, Obesity and Cardiovascular Complications Research Centre and the director of the new Cardiometabolic Health, Diabetes and Obesity Research Network of the province of Quebec. Dr. Carpentier’s research interests include the investigation of postprandial fatty acid metabolism and brown fat metabolism in the development of type 2 diabetes and cardiovascular diseases. He also investigates the anti-diabetic mechanisms of bariatric surgery. His research funding includes grants from the Canadian Institutes of Health Research (CIHR), the Canadian Diabetes Association (CDA), and the Fonds de recherche en santé du Québec (FRSQ). Dr. Carpentier has been a member of numerous scientific panels for granting agencies including the CDA, CIHR, FRSQ and HSFC. He is also a member of the Advisory Editorial Board for Diabetes. Dr. Carpentier has published more than 200 peer-reviewed abstracts and communications and 85 peer-reviewed publications. He is the recipient for multiple awards, including the Heart and Stroke Foundation of Quebec’s Jonathan-Ballon Award (2004), the 2009 André-Dupont Young Scientist Award of the Club de recherche clinique du Québec, the 2011 Young Diabetes Investigator Award from the Canadian Society of Endocrinology and Metabolism and the 2012 Young Investigator Award from the Canadian Diabetes Association.
|
 |
David C.W. Lau, MD, PhD, FRCPCPresident, Obesity Canada Editor-in-Chief, Canadian Journal of Diabetes Professor of Medicine, Biochemistry & Molecular Biology, Cardiac Sciences Julia McFarlane Diabetes Research Centre Chair, Diabetes and Endocrine Research Group Dr. David Lau is Professor of Medicine, Biochemistry and Molecular Biology, and Cardiac Sciences at the University of Calgary. He is currently the Editor-in-Chief of the Canadian Journal of Diabetes, President of Obesity Canada, and Vice-President, Canadian Association of Bariatric Physicians and Surgeons. Dr. Lau is a practising endocrinologist who specializes in diabetes, obesity and lipid disorders. His research interests include fat cell biology in health and obesity, development of insulin resistance in obesity and diabetes, and cellular mechanisms of diabetic vascular complications. He is also involved in population health and clinical research programmes in diabetes, obesity and lipid disorders. Dr. Lau has published over 100 scientific papers in peer-reviewed medical journals, periodicals and books. Dr. Lau was Chair of the evidence-based Obesity Canada Clinical Practice Guidelines (CPG) Steering Committee and Expert Panel, and lead author of the 2007 CPG publication in the Can. Med. Assoc. Journal. Dr. Lau was a member of the 1998, 2003 and 2008 Canadian Diabetes Association Clinical Practice Guidelines Expert Panel, as well as the expert panel of the 2009 Canadian Cardiovascular Society Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult. Dr. Lau is a member of the expert panel committee on the 2013 CDA CPG as well as the 2012 Canadian dyslipidemia CPD update. In 2004, Dr. Lau was honored as the top 20 notable Calgarians, and top 50 Albertans for his exemplary contributions to improve the health of Albertans.
|